Clinical Trials
Study Title:
A Phase 2 Open Label Single Arm Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
|
For more information about the trial above please contact the study team:
|